MMSL 2018, 87(88):63

DISCOVERY AND DEVELOPMENT OF NEUROPROTECTIVE AND DISEASE-MODIFYING ANTI-AD DRUG LEADS FROM THE CHINESE MEDICINEMeeting abstracts

Marvin Mak1,2, Wei Cui3, Yifan Han1,2
1 State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, PR China
2 Department of Applied Biology and Chemical Technology, Institute of Modern Chinese Medicine, The Hong Kong Polytechnic University, Hong Kong
3 School of medicine, Ningbo University, Zhejiang, China

Alzheimer's disease (AD) represents a chronic and progressive brain disorder, and has now become the most common neurodegenerative disorders among the older population. Although the disease is now seen as major public health problems, the currently available therapeutics only offer temporary symptomatic relieves. Therefore, research and development of more effective and disease-modifying agents for the prevention and/or treatment of AD will have tremendous value from both scientific and economic standpoints.

 Over the past few years, our series of studies have identified some highly promising anti-AD drug leads, including those derived from the Chinese medicines, with disease-modifying potential. In this presentation, the multi-neuroprotective effects and the underlying mechanisms of those promising candidates will be comprehensively illustrated and discussed.

Keywords: Neuroprotective effect; Dimers; Alzheimer’s disease; Disease modifying; Multiple functions

Published: September 2, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mak, M., Cui, W., & Han, Y. (2018). DISCOVERY AND DEVELOPMENT OF NEUROPROTECTIVE AND DISEASE-MODIFYING ANTI-AD DRUG LEADS FROM THE CHINESE MEDICINE. MMSL87(Suppl.1), 63
Download citation